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1. Introduction
Atypical polypoid adenomyoma (APA) is a rare benign mixed epi-
thelial and mesenchymal tumor (Hendrickson et al., 2003). Histologi-
cally APA is characterized by a mixture of benign endometrial glands
with structural atypia and a prominent cellular, smooth muscle stroma.
Although APA is considered a benign disease, it may recur, fur-
thermore it is reported a frequent APA coexistence with endometrioid
adenocarcinoma of the endometrium or with atypical endometrial hy-
perplasia and the possibility of APA progression to endometrioid ade-
nocarcinoma of the endometrium (Yamagami et al., 2015; Inoue et al.,
2014; Nomura et al., 2015).
APA is often diagnosed in childbearing and premenopausal patients,
with the reported median age of 40 years (Yamagami et al., 2015;
Longacre et al., 1996; Young et al., 1986; Di Spiezio Sardo et al., 2008).
In post-menopause hysterectomy is the treatment of choice, while in
patients who may want to preserve the fertility potential a conservative
surgical procedure has been suggested (Matsumoto et al., 2013;
Yamagami et al., 2015; Nomura et al., 2015; Di Spiezio Sardo et al.,
2008).
We report the case of a patient who experienced 2 recurrences of
APA after conservative hysteroscopic resections, submitted to hormonal
treatment with levonorgestrel releasing intrauterine system for
12 months. Afterwards she was referred to our Fertility Center and
conceived after induction of ovulation with clomiphene. She delivered
a baby boy by caesarian section.
2. Case report
A 32-years old woman (gravida 0) was referred to the Department of
Obstetrics and Gynecology of University of Milan, Italy (Macedonio
Melloni Hospital), after an histological diagnosis of APA in November
2012. She complained of heavy menstrual bleeding with a mild anemia.
Her physical examination was unremarkable. Transvaginal ultrasound
(TVS) revealed the presence of a hyperechoic lesion in the uterine
cavity suspicious for an endometrial polyp. Consequently, an operative
hysteroscopy under general anesthesia with resectoscopic treatment of
the lesion was performed with histological diagnosis of APA. The
patient was then evaluated every 3 months by TVUS and diagnostic
hysteroscopy with endometrial biopsy for the ﬁrst 6 months.
Afterwards the patient was followed up by TVUS every 6 months.
In March 2014, a suspicious endometrial polyp was diagnosed
during her follow up with TVUS. Resection with operative hysteroscopy
was then performed (Fig. 1) with ﬁnal histology of recurrent APA.
She continued the follow up with diagnostic hysteroscopy with
biopsies every four months and in September 2014 biopsies reveled
APA recurrence, treated again by conservative hysteroscopic resection.
After the 2nd recurrence of APA, due to her strong desire of child-
bearing, an adjuvant progestin intrauterine treatment was suggested.
After a detailed informed consent was signed, a levonorgestrel releasing
IUD was placed in December 2014. Diagnostic hysteroscopy was per-
formed every 3–4 months starting from March 2015 conﬁrming no sign
of recurrence. No side eﬀects related to IUD were observed.
After 12 months of treatment the IUD was removed and the patient
was referred to our Fertility Center to shorten the time to pregnancy.
Ovulation induction with clomiphene 50 mg starting from the 3rd day
for 7 days was obtained. After just one cycle she conceived. The preg-
nancy course was uneventful, except for an observational hospitaliza-
tion at 28th weeks for uterine contractile activity and reduction of the
cervix length. The patient was discharged 2 days later with local pro-
Fig. 1. Macroscopic aspect of atypical polypoid adenomyoma during hysteroscopy.
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gestin therapy. A baby boy weighing 3890 g was delivered by caesarian
section for maternal request at 39 weeks. Placenta histology and uterine
curettage carried out during cesarian section were normal.
Two months after the caesarian section the patient underwent a
diagnostic hysteroscopy with biopsies for persistent mild vaginal
bleeding and thickened endometrium, the specimens revealed only the
presence of necrotic deciduas.
3. Discussion
The pathogenesis of APA is unknown. The presence of estrogen and
progesterone receptors (Terada, 2011) suggests an hormonal inﬂuence
and may support an hormonal treatment.
Hysteroscopic resection of the lesion and careful follow up has been
proposed by some authors with encouraging results. Di Spiezio Sardo
et al. (2008) proposed a four-step technique resection (step 1: the re-
moval of the APA, step 2: the removal of endometrium sideward to the
lesion, step 3: the removal of the myometrium under the lesion, step 4:
random endometrial biopsies). Dilatation and curettage is an alter-
native treatment. However, hysteroscopic resection seems to reduce
recurrence (Matsumoto et al., 2013).
Medical treatment by using medroxyprogesterone acetate was pro-
posed by Nomura et al. (2015) in 18 patients (13 patients with APA, 4
patient with APA coexisting with endometrial adenocarcinoma, 1 pa-
tient with APA coexisting with atypical endometrial hyperplasia) di-
agnosed after dilatation and curettage. On 18 patients studied, 14
achieved a partial or complete response, 8 had a recurrence, 10 even-
tually underwent hysterectomy, 9 developed endometrial cancer. In
patients under 35 years, 4 out of 5 had children (Table 1). Levo-
norgestrel IUD was suggested as maintenance therapy.
Yamagami et al. (2015) treated 3 young patients with APA coex-
isting with endometrioid adenocarcinoma of the endometrium or with
atypical endometrial hyperplasia with high dose of medrox-
yprogesterone acetate achieving pregnancy in all of them after com-
plete hysteroscopic response to treatment (Table 1).
Several studies have reported the safety of progestins in young pa-
tients aﬀected by endometrial adenocarcinoma at stage IA, grade 1, or
atypical endometrial hyperplasia desiring to preserve their re-
productive potential. Although no deﬁnitive consensus exists regarding
the optimal progestin regimen and duration, levonorgestrel intrauterine
system was suggested to reduce side eﬀects of medroxyprogesterone
acetate and megestrol acetate (Gunderson et al., 2012).
To our knowledge, this is the ﬁrst report of conservative treatment
of recurrent APA with a local hormonal therapy with levonorgestrel
IUD. Firstly, no side eﬀects were reported. Secondly, there was no im-
pairment on a subsequent pregnancy. Although a larger case series is
necessary to conﬁrm the eﬃcacy and safety of this treatment, this case
supports the eﬀectiveness of levonorgestrel IUD in treatment of re-
current APA in young women who desire to preserve fertility.
Follow up should be performed for a long time. Recurrence with
endometrial cancer has been diagnosed up to 8 years after treatment by
Inoue et al. (2014). Standard follow up should include TVUS and di-
agnostic hysteroscopy in case of suspicious lesions.
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Table 1
Outcome of treatment of APA with hormonal therapy in literature (MPA: medroxyprogesterone acetate; APA atypical polypoid adenomyoma; EC: endometrial carcinoma; AEH: atypical
endometrial hyperplasia).
Author Journal Treatment N. patients Histology Response to
therapy
APA
Persistence
APA
Recurrence
Final diagnosis
of EC
Pregnancy
Nomura et al.
(2015)
Arch Gynecol
Obstet 2015
MPA 200–600 mg/day
for 6–9 months
18 APA (13)
APA + EC (4)
APA + AEH (1)
14 4 8 9 4
Yamagami et al.
(2015)
J Obstet
Gynecol Res
2015
MPA 600 mg/day for
6 months
3 APA + EC (1)
APA + AEH (2)
3 0 1 0 3
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